Short answer · Medically reviewed summary · Last updated: 2026-05-08
The ICD-10 code for Tardive Dyskinesia is G24.01, while the corresponding ICD-9 code is 333.82. These codes are essential for medical documentation and billing, representing the movement disorder characterized by involuntary, repetitive body movements caused by long-term use of antipsychotic medications. What is the clinical definition of Tardive Dyskinesia? Tardive Dyskinesia is a hyperkinetic movement disorder typically appearing after months or years of exposure to dopamine receptor-blocking agents, such as antipsychotics or certain anti-nausea medications.
The ICD-10 code for Tardive Dyskinesia is G24.01, while the corresponding ICD-9 code is 333.82. These codes are essential for medical documentation and billing, representing the movement disorder characterized by involuntary, repetitive body movements caused by long-term use of antipsychotic medications.
Tardive Dyskinesia is a hyperkinetic movement disorder typically appearing after months or years of exposure to dopamine receptor-blocking agents, such as antipsychotics or certain anti-nausea medications. For the 23 members of the DiseaseMaps community currently navigating Tardive Dyskinesia, these involuntary movements—often involving the tongue, lips, jaw, and limbs—can be both physically exhausting and emotionally distressing.
Diagnosis of Tardive Dyskinesia is primarily clinical, relying on a thorough neurological examination and a comprehensive review of medication history. Clinicians often utilize standardized tools to grade the severity of movements, such as the Abnormal Involuntary Movement Scale (AIMS). Because Tardive Dyskinesia symptoms can fluctuate, maintaining a detailed diary of observed movements is highly recommended for patients.
Recognizing the signs of Tardive Dyskinesia early is critical for management. Common manifestations include:
While the prospect of a movement disorder can feel overwhelming, management strategies for Tardive Dyskinesia have evolved. Approaches often involve working with a psychiatrist or neurologist to adjust the causative medication, or in some cases, the introduction of VMAT2 inhibitors, which are FDA-approved specifically to treat Tardive Dyskinesia symptoms.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.